The Study of Cost-Effectiveness of Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Who Developed Ischemic Stroke.

Jaberi, Neda; Kavosi, Zahra; Hooshmandi, Etrat; Moradi, Nasrin; Keshavarz, Khosro; Borhani-Haghighi, Afshin

Jaberi, Neda; Kavosi, Zahra; Hooshmandi, Etrat; Moradi, Nasrin; Keshavarz, Khosro; Borhani-Haghighi, Afshin.

Afiliação

Jaberi N; Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Kavosi Z; Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Hooshmandi E; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Moradi N; Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Keshavarz K; Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Borhani-Haghighi A; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Stroke Res Treat ; 2021: 5534873, 2021.

Article em En | MEDLINE | ID: mdl-34531970

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google